Quantum-Si Reports Q1 2026 Results: Revenue Plunges 69% Amid Proteus Launch Anticipation, EPS Beats Estimates
QSI sits 35% above its 52-week low of $0.691.
Summary
Quantum-Si Inc. reported a significant 69.4% year-over-year revenue decline to $258,000 for Q1 2026, primarily due to customer deferrals ahead of its Proteus platform launch, while its net loss increased to $21.7 million, though EPS of $(0.10) beat analyst expectations.
Key Events · Earnings and Guidance · QSI
-
Q1 2026 Revenue Plunges 69%
Total revenue decreased 69.4% year-over-year to $258,000, primarily driven by lower sales volumes of instruments and consumables as customers deferred purchasing decisions in anticipation of the Proteus platform launch.
-
Net Loss Increases, EPS Beats Estimates
Net loss increased to $21.7 million for Q1 2026 from $19.2 million in Q1 2025. However, basic and diluted net loss per share of $(0.10) was better than the $(0.11) loss expected by analysts.
-
Liquidity Position and Cash Burn
The company held $190.4 million in cash, cash equivalents, and marketable securities as of March 31, 2026. Net cash used in operating activities for the quarter was $25.6 million, with management stating current liquidity is sufficient for at least the next twelve months.
-
Legal Settlement Finalized
A Delaware Stockholder Litigation was settled on March 27, 2026. The company paid $3.0 million, with the remaining $4.6 million of the $8.0 million liability funded by insurance proceeds, resolving this contingency.
Analysis · QSI · Industrial Applications And Services
Quantum-Si Inc.'s first-quarter 2026 financial results show a substantial 69.4% year-over-year decline in total revenue to $258,000. This significant drop is primarily attributed to customers deferring purchases in anticipation of the Proteus next-generation platform, which is expected to launch by the end of 2026. This indicates a material near-term operational challenge and potential continued revenue headwinds. While the net loss increased to $21.7 million, the reported basic and diluted net loss per share of $(0.10) was better than the $(0.11) loss expected by analysts, offering a mixed signal. The company reported $190.4 million in cash, cash equivalents, and marketable securities, which management believes is sufficient to fund operations for at least the next twelve months. Additionally, a Delaware Stockholder Litigation was finalized, resolving a prior $8.0 million liability. Investors should closely monitor the Proteus launch and its subsequent impact on sales and market adoption.
At the time of this filing, QSI was trading at $0.93 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $212.2M. The 52-week trading range was $0.69 to $3.10. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.